U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H14N2O4S
Molecular Weight 318.348
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of BELINOSTAT

SMILES

ONC(=O)\C=C\C1=CC(=CC=C1)S(=O)(=O)NC2=CC=CC=C2

InChI

InChIKey=NCNRHFGMJRPRSK-MDZDMXLPSA-N
InChI=1S/C15H14N2O4S/c18-15(16-19)10-9-12-5-4-8-14(11-12)22(20,21)17-13-6-2-1-3-7-13/h1-11,17,19H,(H,16,18)/b10-9+

HIDE SMILES / InChI

Molecular Formula C15H14N2O4S
Molecular Weight 318.348
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 15:35:41 UTC 2023
Edited
by admin
on Fri Dec 15 15:35:41 UTC 2023
Record UNII
F4H96P17NZ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BELINOSTAT
DASH   INN   MI   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
BELINOSTAT [VANDF]
Common Name English
N-HYDROXY-3-(3-((PHENYLAMINO)SULFONYL)PHENYL)-2-PROPENAMIDE
Systematic Name English
NSC-726630
Code English
2-PROPENAMIDE, N-HYDROXY-3-(3-((PHENYLAMINO)SULFONYL)PHENYL)-, (2E)-
Systematic Name English
PX-105684
Code English
BELEODAQ
Brand Name English
BELINOSTAT [USAN]
Common Name English
BELINOSTAT [ORANGE BOOK]
Common Name English
2-PROPENAMIDE, N-HYDROXY-3-(3-((PHENYLAMINO)SULFONYL)PHENYL)-
Systematic Name English
PXD-101
Code English
BELINOSTAT [MI]
Common Name English
(2E)-N-HYDROXY-3-(3-(PHENYLSULFAMOYL)PHENYL)PROP-2-ENAMIDE
Systematic Name English
Belinostat [WHO-DD]
Common Name English
PXD101
Code English
belinostat [INN]
Common Name English
N-Hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide
Systematic Name English
Classification Tree Code System Code
NDF-RT N0000175588
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
WHO-ATC L01XX49
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
FDA ORPHAN DRUG 289309
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
NCI_THESAURUS C1946
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
EU-Orphan Drug EU/3/13/1151
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
Code System Code Type Description
ChEMBL
CHEMBL408513
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
NCI_THESAURUS
C48812
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
EPA CompTox
DTXSID60194378
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
MERCK INDEX
m2295
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY Merck Index
IUPHAR
7496
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
NSC
726630
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
USAN
SS-19
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
RXCUI
1543543
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY RxNorm
CHEBI
61076
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
INN
8823
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
FDA UNII
F4H96P17NZ
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
DRUG CENTRAL
4876
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
DAILYMED
F4H96P17NZ
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
SMS_ID
100000144569
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
CAS
866323-14-0
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
PUBCHEM
6918638
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
WIKIPEDIA
BELINOSTAT
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
CAS
414864-00-9
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
NON-SPECIFIC STEREOCHEMISTRY
EVMPD
SUB121262
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
DRUG BANK
DB05015
Created by admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
PRIMARY
Related Record Type Details
TARGET->LIGAND
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
BINDER->LIGAND
BINDING
METABOLIC ENZYME -> SUBSTRATE
Related Record Type Details
METABOLITE INACTIVE -> PARENT
MEDIATOR: UGT1A1
MAJOR
PLASMA; URINE
METABOLITE -> PARENT
The enzymes responsible for the formation of 3-(anilinosulfonyl)-benzenecarboxylic acid, (3-ASBA) are not known.
METABOLITE -> PARENT
PLASMA; URINE
METABOLITE -> PARENT
Belinostat also undergoes hepatic metabolism by CYP2A6, CYP2C9, and CYP3A4 enzymes to form belinostat amide and belinostat acid.
METABOLITE -> PARENT
METABOLITE -> PARENT
Belinostat also undergoes hepatic metabolism by CYP2A6, CYP2C9, and CYP3A4 enzymes to form belinostat amide and belinostat acid.
MAJOR
PLASMA; URINE
METABOLITE -> PARENT
MAJOR
PLASMA; URINE
METABOLITE INACTIVE -> PARENT
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC